Biotechnology, CAR - T Cell therapy, CAR T-Cell, CAR therapy, China, fund raise, Oricell Therapeutics
Oricell raises additional $45M USD to expand its CAR T-Cell therapy to United States
23rd March 2023: The preclinical and early-stage cancer cell therapies being developed by Shanghai biotech Oricell have received an additional $45 million in funding, the company announced on Tuesday. Following a showing at AS..